FAQ

octreotide pamoate

Known as: OP LAR, Octreotide Embpnate, Octreotide Pamoate LAR(SMS 201-995) 
A synthetic long-acting octapeptide analogue of endogenous somatostatin. Octreotide pamoate binds to somatostatin receptors expressed by some… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2010
01219982010

Related topics

Related topics

5 relations
OctreotidePositive Regulation of ApoptosisReceptor Activation ProcessSomatostatin Receptor

Narrower (1)

OncoLar

Related mentions per year

Related mentions per year

1966-2018
1960198020002020
octreotide pamoate
Receptor Activation Process
Octreotide
Somatostatin Receptor
Positive Regulation of Apoptosis
OncoLar

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.
Known agonists of the orphan receptor GPR35 are kynurenic acid, zaprinast, 5-nitro-2-(3-phenylproplyamino) benzoic acid, and… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy.
The insulin-like growth factor (IGF)-system was evaluated in 150 breast cancer patients participating in a randomised phase III… (More)
Is this relevant?
2004
2004
High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours.
OBJECTIVE High-dose somatostatin analogue treatment has shown an antiproliferative effect in one study including patients with… (More)
Is this relevant?
2002
2002
A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma.
BACKGROUND Long-acting release octreotide pamoate (OP-LAR) is a synthetic octapeptide that can be administered monthly and whose… (More)
Is this relevant?
2002
2002
A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth…
PURPOSE The purpose of this research was to determine whether insulin-like growth factor (IGF) suppression, using a long-acting… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
1998
1998
Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study.
Fourteen patients suffering from advanced colorectal (n = 7), pancreatic (n = 4) or gastric (n = 3) carcinomas received treatment… (More)
  • table 1
  • table 2
Is this relevant?